SCHEMBL17825957

SCHEMBL17825957

COc1ccc(CNc2ncnc3c2ncn3C2O[C@H](CO)[C@@H](O)[C@@H]2O)o1

nearest known ligand 0.72

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ ADORA3 P0DMS8 4/20 0.69
▸ TP53 P04637 3/20 0.69
▸ SLC29A1 Q99808 3/20 0.69
▸ PAX8 Q06710 2/20 0.69
▸ SMN1; SMN2 Q16637 1/20 0.69
▸ MITF O75030 1/20 0.69
▸ LMNA P02545 1/20 0.69
▸ TDP1 Q9NUW8 1/20 0.67
▸ ADORA2A P29274 2/20 0.66
▸ ADORA1 P30542 2/20 0.66
▸ TSHR P16473 1/20 0.65
▸ NFKB1 P19838 1/20 0.65
▸ STAT6 P42226 1/20 0.65
▸ GMNN O75496 1/20 0.65
▸ BLM P54132 1/20 0.65
▸ PMP22 Q01453 1/20 0.65

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19583002 1.00 ADORA3 (0.69) ADORA3TP53SLC29A1PAX8SMN1; SMN2
SCHEMBL25173768 0.99 ADORA3 (0.68) ADORA3TP53SLC29A1PAX8SMN1; SMN2
SCHEMBL14714035 0.90 ADORA3 (0.72) ADORA3TP53SLC29A1PAX8SMN1; SMN2
SCHEMBL20626317 0.90 ADORA3 (0.72) ADORA3TP53SLC29A1PAX8SMN1; SMN2
SCHEMBL28021059 0.90 ADORA3 (0.72) ADORA3TP53SLC29A1PAX8SMN1; SMN2
SCHEMBL14713281 0.90 ADORA3 (0.72) ADORA3TP53SLC29A1PAX8SMN1; SMN2
SCHEMBL19583113 0.90 ADORA3 (0.72) ADORA3TP53SLC29A1PAX8SMN1; SMN2
SCHEMBL20626318 0.90 ADORA3 (0.72) ADORA3TP53SLC29A1PAX8SMN1; SMN2
SCHEMBL17825992 0.90 ADORA3 (0.72) ADORA3TP53SLC29A1PAX8SMN1; SMN2
SCHEMBL17825928 0.87 SLC29A1 (0.73) ADORA3TP53SLC29A1PAX8SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3229772-A1 6-ARYL-9-GLYCOSYLPURINES AND USE THEREOF Univerzita Palackého v Olomouci (CZ) 2017-10-18 — — EP claimed
WO-2016091236-A1 6-ARYL-9-GLYCOSYLPURINES AND USE THEREOF UNIVERZITA PALACKEHO V OLOMOUCI (CZ) 2016-06-16 — — WO claimed
EP-3229772-A1 6-ARYL-9-GLYCOSYLPURINES AND USE THEREOF Univerzita Palackého v Olomouci (CZ) 2017-10-18 — — EP disclosed
WO-2016091236-A1 6-ARYL-9-GLYCOSYLPURINES AND USE THEREOF UNIVERZITA PALACKEHO V OLOMOUCI (CZ) 2016-06-16 — — WO disclosed
Send feedback